Atom Investors »

Ovid Therapeutics shares owned by Atom Investors

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Atom Investors from 13F filings

Historical chart of Atom Investors investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Atom Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Atom Investors

Quarter filed Position value Share count Share price at filing
2026-06-30 $677k 252k 2.69

More positions owned by Atom Investors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Viatris (VTRS)
Intel Corporation (INTC)
Hewlett Packard Enterprise (HPE)
Rhythm Pharmaceuticals (RYTM)
Esab Corporation (ESAB)
Ishares Msci Brazil Etf (EWZ)
Gxo Logistics Incorporated Common Stock (GXO)
Applied Materials (AMAT)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
VSE Corporation (VSEC)
Apple (AAPL)
Immunome (IMNM)
John Bean Technologies Corporation (JBTM)

View all positions for Atom Investors

Top funds holding Ovid Therapeutics

Jupiter Topco
Eventide Asset Management
BlackRock
Henderson Group
RA Capital Management
Affinity Asset Advisors
Vanguard Capital Management
ADAR1 Capital Management
Balyasny Asset Management
Adage Capital Partners GP
Federated Investors
Braidwell
Geode Capital Management
Silverarc Capital Management
Stempoint Capital

View all funds holding Ovid Therapeutics